Family Offices Financing Early Stage Companies: Challenges and Opportunities
Presented by New England Healthcare Executive Network
Foley Hoag LLP
155 Seaport Boulevard
Boston, MA 02210-2600
Hear from industry leaders on the latest trends in Family Office investments and predictions for 2020.
Family Office investment funds are major players in the growth path of healthcare companies. As investors such as Venture Capital and Private Equity have been the focal points of capital raising strategies, Family Office investors are becoming increasingly sophisticated and making direct investments into healthcare startups. When it comes to deal volume, Family Offices startup investment activity tracks with the broader venture investment market which includes individual angels, venture capital groups, seed funds, and accelerators.
Chuck Stetson, the CEO of the Stetson Family Office will be the keynote speaker. The Stetson Family Office recently started Healthcare Impact Foundation, a 501-C-3 evergreen organization to bring capital and management expertise to life science companies at all stages.
Following Chuck Stetson remarks, the panel will share their investment experiences with Family Office investors. Ask questions and contribute your insights during an interactive audience segment and identify potential new investment strategies.
Chuck Stetson, CEO, Stetson Family Office
Mr. Stetson is focused on private equity investments and leases with family offices around the globe in his role as the head of the Association for Corporate Growth (ACG) Global Family Office Council. He has also set up a philanthropic organization, Essentials in Education, which provides world class educational content on Flourishing Through Business.
Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series
Dennis is the author of The Peddler’s Prerogative and The Life Science Executive’s Fundraising Manifesto.
Martha Shadan, President & Chief Executive Officer, Miach Orthopaedics
Martha has more than three decades of experience in the life science industry as a business leader in a variety of both large and start-up organizations.
Hewmun Lau, MS, MBA, Principal, Broadview Ventures, Inc.
Hewmun shares responsibility for the day-to-day investment activities at Broadview Ventures, including identification and screening of new opportunities, due diligence, negotiation of deal structure, and portfolio company board involvement.
Ashley Wittorf, Executive Director & Global Head - Investor Relations, AdvaMed
Ashely is medical device executive with over 15 years of broad industry experience in commercialization strategy and product development. Currently at AdvaMed she responsible for establishment and operation of new division focused on emerging-growth medical technology companies with US revenue less than $100 MM.
Who should attend
C-level executives, board members, investors, and anyone who wants a better understanding of the evolving role of Family Office investors
Click here for more details.